Strategic Advisory Board
The Strategic Advisory Board of Université Paris Cité is a forum for exchange and definition of the strategic choices of the institution. It brings together varied international expertise of the highest level. Its 12 members are responsible for evaluating and identifying the institution’s research and teaching activities as well as its international development and partnership strategy.

Missions
In accordance with the statutes of Université Paris Cité, the ambition of the Strategic Advisory Board is to accompany the governing bodies by providing advice in order to achieve its objectives namely :
- to establish itself as a leading international research-intensive university, covering the fields of exact sciences, life sciences and human and social sciences
- to participate in solving major societal challenges through high-quality research and teaching
- to contribute to innovation, offer students a new and diversified range of courses
- to promote the dialogue between science and society
The Strategic Advisory Board will also evaluate the insitution’s international strategy.
Its two main missions are therefore to evaluate and advise Université Paris Cité with the objective to follow its development trajectory.
Composition
The composition of the Strategic Advisory Board is entirely external, international and diverse. The members have been chosen based on either their direct experience of managing universities, firms and large academic projects, or their involvement as important stakeholders, or their expertise of key strategic issues.
Members
Guy BRETON, Rector, Université de Montréal
Berit EIKA, Pro-Vice-Chancellor, University of Aarhus
Devora GRYNSPAN, Vice-President International Relations, Northwestern University
Catherine LANGLAIS, former Deputy Vice President-Research & Development, Saint-Gobain recherche, President of French Physics Society
Martin LOHSE, Scientific director, Center Max Delbrück, Berlin
Funmi OLONISAKIN, Vice-President International Relations, King’s College
Jan PALMOWSKI, Professor of Modern and Contemporary History, Warwick University; Secretary General to the Guild of European Research-Intensive Universities
Alexandra PALT, Executive Vice-President L’Oréal
Saul PERLMUTTER, astrophysicist at the Lawrence Berkeley National Laboratory & Professor of physics at the University of California, Berkeley, Physics Nobel Prize, 2011
Ed STOLPER, Professor of geology, CalTech
Isabelle THIZON-DE-GAULLE, Head of Scientific Relations and Initiatives, R&D, Sanofi
Mario VARGAS LLOSA, novelist, Literature Nobel Prize, 2010
Read more
![[Programme PAUSE 2023] deuxième appel à candidatures](https://u-paris.fr/wp-content/uploads/2021/09/UPL5814035428872217516_pause_cover-1080x675.jpg)
[Programme PAUSE 2023] deuxième appel à candidatures
Le Collège de France lance un nouvel appel à candidatures pour le programme PAUSE.

Nightline offers a New Digital Resource in English
Nightline is a listening service run by students who are available to talk to their peers about any kind of subject. At Nightline, a new, innovative digital first aid kit has been developed and is now available in English for the international student community. ©...

Recherche et vulgarisation scientifique : rien n’arrête Gaël Fortin, doctorant et entrepreneur !
Après avoir créé un blog et un podcast d’entraide étudiante en parallèle de sa thèse en biologie, Gaël Fortin s’est désormais saisi du statut national d’étudiant-entrepreneur proposé par l’université pour concrétiser ses projets entrepreneuriaux. Il a également ouvert...

Mucoviscidose : le traitement Kaftrio/Kalydeco pourrait être efficace pour près de la moitié des patients sans mutation F508del
L’équipe du Service de Pneumologie/Centre de Référence Maladies Rares de la Mucoviscidose, coordonnée par le Pr Pierre-Régis Burgel, a étudié l’efficacité d’un traitement (Kaftrio/Kalydeco) contre la mucoviscidose chez des patients qui n’en bénéficient pas actuellement du fait de l’absence de mutation F508del.